Johnson & Johnson Securities Litigation (2018)

If you purchased a significant amount of shares of Johnson & Johnson (NYSE: JNJ) between February, 22nd 2013 and February, 7th 2018, and/or if you purchased Johnson & Johnson (NYSE: JNJ) shares in February 2013 or earlier and currently hold any of those shares, you have certain options. Investors should register for updates.


Lawsuit Overview

Defendant:Johnson & Johnson
Date Filed:February, 8th 2018
Sector:Health Care
Industry:Major Pharmaceuticals

According to the law firm press release, the Complaint alleges that throughout the Class Period Defendants made false or misleading statements, and failed to disclose that J&J has known for decades that its talc products include asbestos fibers and that the exposure to those fibers can cause ovarian cancer and mesothelioma. J&J's denials that talc could cause cancer and mesothelioma were materially false and misleading, and the company concealed contingent liabilities and loss of future revenues from the product. As a result of the company's actions, the lawsuit claims, investors suffered damages when the true details entered the market.

Sign up for free to create a personalized portfolio with tracking and e-mail alerts for Johnson & Johnson

First Identified Complaint

Frank Hall, et al. v. Johnson & Johnson, et al.

Date Filed:February, 8th 2018
Class Period Start:February, 22nd 2013
Class Period End:February, 7th 2018
First Identified Complaint Filings
#Document TitleFiling Date